DeLuca H F, Sicinski R R, Tanaka Y, Stern P H, Smith C M
Department of Biochemistry, University of Wisconsin-Madison 53706.
Am J Physiol. 1988 Apr;254(4 Pt 1):E402-6. doi: 10.1152/ajpendo.1988.254.4.E402.
The biological activity of 1,25-dihydroxyvitamin D2 [1,25(OH)2D2] and 24-epi-1,25-dihydroxyvitamin D2 [24-epi-1,25(OH)2D2] has been determined in vitamin D-deficient rats. The biological effectiveness of 1,25(OH)2D2 is equal to that reported previously for 1,25-dihydroxyvitamin D3 [1,25(OH)2D3] (15) in intestinal calcium transport, mineralization of bone, mobilization of bone calcium, and elevation of plasma inorganic phosphorus of rachitic rats. However, 24-epi-1,25(OH)2D2 is at best one-half as active as 1,25(OH)2D2 in stimulating intestinal calcium transport and in the mineralization of rachitic bone. The 24-epi-1,25(OH)2D2 is one-third as active as 1,25(OH)2D3 in binding to the chick intestinal receptor for 1,25(OH)2D3. Thus receptor discrimination may account for the twofold difference in intestinal calcium transport activity. 24-Epi-1,25(OH)2D2 appeared inactive in in vivo mobilization of bone calcium or bone phosphorus. On the other hand, in fetal rat bone in culture, the epi compound was only five times less active than 1,25(OH)2D2 in inducing resorption. Short-term experiments on bone mineral mobilization in vivo show that the 24-epi-1,25(OH)2D2 does induce bone calcium mobilization but that its activity in this respect is short lived. It is suggested that 24-epi-1,25(OH)2D2 and, as a result, it shows preferential activity on intestine whose response to a single dose of 1,25(OH)2D2 remains for several days, whereas the short-lived bone system does not remain stimulated during the 24-h period between doses.
已在维生素D缺乏的大鼠中测定了1,25 - 二羟基维生素D2 [1,25(OH)2D2]和24 - 表 - 1,25 - 二羟基维生素D2 [24 - epi - 1,25(OH)2D2]的生物活性。1,25(OH)2D2在肠道钙转运、骨矿化、骨钙动员以及佝偻病大鼠血浆无机磷升高方面的生物有效性与先前报道的1,25 - 二羟基维生素D3 [1,25(OH)2D3]相当(15)。然而,24 - epi - 1,25(OH)2D2在刺激肠道钙转运和佝偻病骨矿化方面的活性充其量仅为1,25(OH)2D2的一半。24 - epi - 1,25(OH)2D2与鸡肠道1,25(OH)2D3受体结合的活性仅为1,25(OH)2D3的三分之一。因此,受体识别可能是肠道钙转运活性存在两倍差异的原因。24 - epi - 1,25(OH)2D2在体内骨钙或骨磷动员方面似乎无活性。另一方面,在培养的胎鼠骨中,该表位化合物在诱导吸收方面的活性仅比1,25(OH)2D2低五倍。体内骨矿物质动员的短期实验表明,24 - epi - 1,25(OH)2D2确实能诱导骨钙动员,但它在这方面的活性持续时间很短。有人提出,24 - epi - 1,25(OH)2D2对肠道具有优先活性,因为肠道对单剂量1,25(OH)2D2的反应会持续数天,而在两次给药间隔的24小时内,短暂激活的骨系统不会持续受到刺激。